<DOC>
	<DOCNO>NCT00569699</DOCNO>
	<brief_summary>The purpose study determine whether S-1 bevacizumab safe treatment unresectable recurrent colorectal cancer</brief_summary>
	<brief_title>Phase II Trial Combination Therapy With Bevacizumab S-1 Elderly Patients With Unresectable Recurrent Colorectal Cancer ( BASIC )</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>1 . Histologically confirm colorectal carcinoma inoperable , locally advanced , metastatic disease , amenable curative therapy 2 . Measurable disease nonmeasurable assessable disease accord Response Evaluation Criteria Solid Tumors ( RECIST ) 3 . Patients previous treatment ( radiotherapy chemotherapy ) . Patients receive postoperative adjuvant chemotherapy eligible relapse diagnose 180 day end treatment . 4 . Treatment FOLFIRI FOLFOX indicate . 5 . Age &gt; 65 year 6 . Life expectancy least 3 month 7 . ECOG PS 0 , 1 , 2 8 . Adequate function major organ define : 1 . Hemoglobin &gt; 9.0 g/dL 2 . White blood cell count &gt; 3,500/mm3 , &lt; 12,000/mm3 3 . Neutrophil count &gt; 1,500/mm3 4 . Platelet count &gt; 100,000/mm3 5 . Total bilirubin &lt; 1.5 mg/dL 6 . AST ALT &lt; 100 U/L ( &lt; 200 U/L patient liver metastasis ) 7 . Serum creatinine &lt; 1.2 mg/dL 8 . Creatinine clearance estimate CockcroftGault method &gt; 50 mL/min 9 . Able take capsule orally . 10 . No electrocardiographic abnormality within 28 day enrollment would clinically preclude execution study , judge investigator . 11 . Voluntary write informed consent . 1 . Serious drug hypersensitivity history drug allergy 2 . Active double cancer 3 . Active infection ( e.g. , patient pyrexia 38â„ƒ high ) 4 . Uncontrolled hypertension 5 . Serious complication ( e.g. , pulmonary fibrosis , interstitial pneumonitis , heart failure , renal failure , hepatic failure , poorly control diabetes ) 6 . Moderate severe ascites pleural effusion require treatment 7 . Watery diarrhea 8 . Treatment flucytosine 9 . Metastasis CNS 10 . Pregnant woman , possibly pregnant woman , woman wish become pregnant , nursing mother . Men currently attempt conceive child . 11 . Severe mental disorder 12 . Continuous treatment steroid 13 . Urine dipstick proteinuria &lt; 2+ 14 . Thrombosis , cerebral infarction , myocardial infarction , pulmonary embolism 15 . Major surgical procedure , open biopsy , clinically significant traumatic injury within 4 week 16 . Longterm daily treatment aspirin ( &gt; 325 mg/day ) 17 . History evidence inherit bleed diathesis coagulopathy risk bleed 18 . Judged ineligible participation study investigator safety reason .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>S-1</keyword>
	<keyword>Bevacizumab</keyword>
</DOC>